Patients’ Experiences During the Long Journey Before Initiating Migraine Prevention with a Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody (mAb)

Patients’ Experiences During the Long Journey Before Initiating Migraine Prevention with a Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody (mAb)

Abstract Introduction Migraine is under-diagnosed and under-treated. Many people with migraine do not seek medical care, and those who do may initially receive a different diagnosis and/or be dissatisfied with provided care on their journey before treatment with a CGRP-mAb (calcitonin-gene-related-p...

Full description

Bibliographic Details
Main Authors: Elizabeth Seng, Christian Lampl, Lars Viktrup, William R. Lenderking, Hayley Karn, Margaret Hoyt, Gilwan Kim, Dustin Ruff, Michael H. Ossipov, Maurice Vincent
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-09-01
Series:Pain and Therapy
Subjects:
Chronic migraine
Episodic migraine
Galcanezumab
CGRP monoclonal antibodies
Online Access:https://doi.org/10.1007/s40122-024-00652-z

Internet

https://doi.org/10.1007/s40122-024-00652-z

Similar Items